UpDoc Leads ARPA-H Program for Clinical AI Care
Palo Alto, California, U.S., September 9, 2026 UpDoc has been selected by the Advanced Research Projects Agency for Health...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
Palo Alto, California, U.S., September 9, 2026 UpDoc has been selected by the Advanced Research Projects Agency for Health...
Menlo Park, California, August 20, 2026 Subtle Medical, a provider of AI-powered medical imaging solutions, has appointed Lawrence N....
Greenville, North Carolina, August 19, 2026 Arcato Laboratories, Inc. has announced positive topline results from its first-in-human Phase 1...
Jena, Germany, August 19, 2026 ZEISS Medical Technology, part of Carl Zeiss Meditec AG, has announced that the U.S....
Coral Gables, Florida, August 18, 2026 Sitero, a global clinical research organization (CRO) and clinical technology company, has announced...
New York, August 18, 2026 Enhanced Group, Inc. (NYSE: ENHA) has announced Enhanced OS, an AI-powered platform designed to...
Orlando, Florida, USA, August, 10, 2026 Independent research from the Medical University of South Carolina (MUSC) Telehealth Center of...
ORLANDO, Fla., July 30, 2026 Andor Health announced that its AI-native clinical services operating platform, ThinkAndor®, has reached General...
CHICAGO, Ill., July 23, 2026 SimBioSys®, an AI-driven precision medicine company, has announced a strategic partnership with Ferrum Health...
NEW YORK, June 25, 2026 Aidoc announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device...
